Total Funding
60
71
Total FundingSeries A raised
Growth Score
1 pts
Heat Score
12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
13763
Delphia Therapeutics operates and manages a laboratory that develops treatments for cancer cells.
- Reza Mazhari: Chief Business OfficerPast Role: Novartis, Head of Search & Evaluation, North America, Business Development & Licensing
- Kevin Marks: President & CEOPast Role: Novartis, head of oncology drug discovery
About the Company
Delphia Therapeutics operates and manages a laboratory that develops treatments for cancer cells. It studies cancer-driving pathways and their effect on creating cancer medicines. Delphia Therapeutics is based in Boston, USA.
